Julia Schweiger

1.8k total citations · 1 hit paper
24 papers, 1.0k citations indexed

About

Julia Schweiger is a scholar working on Psychiatry and Mental health, Physiology and Pharmacology. According to data from OpenAlex, Julia Schweiger has authored 24 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Psychiatry and Mental health, 6 papers in Physiology and 5 papers in Pharmacology. Recurrent topics in Julia Schweiger's work include Diet and metabolism studies (6 papers), Treatment of Major Depression (5 papers) and Schizophrenia research and treatment (5 papers). Julia Schweiger is often cited by papers focused on Diet and metabolism studies (6 papers), Treatment of Major Depression (5 papers) and Schizophrenia research and treatment (5 papers). Julia Schweiger collaborates with scholars based in United States, Iceland and Germany. Julia Schweiger's co-authors include John W. Newcomer, Dan Haupt, Angela K. Melson, Robert Fucetola, Benjamin P. Cooper, Gregg Selke, Michael Yingling, Ginger E. Nicol, Eric J. Lenze and Angela Stevens and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Julia Schweiger

24 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19

2020 333 citations Eric J. Lenze, Caline Mattar et al. JAMA profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Julia Schweiger United States	10	429	250	218	197	186	24	1.0k
Daniel Kopf Germany	21	225 0.5×	397 1.6×	282 1.3×	58 0.3×	160 0.9×	77	1.3k
Einat Peles Israel	28	241 0.6×	98 0.4×	330 1.5×	122 0.6×	288 1.5×	109	2.6k
Miriam Adelson Israel	29	319 0.7×	85 0.3×	341 1.6×	88 0.4×	351 1.9×	113	2.9k
Chiao‐Chicy Chen Taiwan	23	815 1.9×	115 0.5×	145 0.7×	143 0.7×	250 1.3×	45	1.9k
Jens Bohlken Germany	19	441 1.0×	63 0.3×	230 1.1×	141 0.7×	232 1.2×	106	1.5k
Otto Lesch Austria	20	180 0.4×	78 0.3×	154 0.7×	177 0.9×	144 0.8×	62	1.3k
Rachel Vickers‐Smith United States	17	110 0.3×	82 0.3×	127 0.6×	50 0.3×	165 0.9×	57	1.4k
Susan G. Leckband United States	13	1.4k 3.3×	107 0.4×	312 1.4×	201 1.0×	91 0.5×	24	2.2k
Jonathan G. Leung United States	15	339 0.8×	43 0.2×	86 0.4×	258 1.3×	52 0.3×	92	1.0k
Heike Hunger Germany	13	1.5k 3.4×	233 0.9×	248 1.1×	163 0.8×	148 0.8×	14	1.9k

Countries citing papers authored by Julia Schweiger

Since Specialization

Citations

This map shows the geographic impact of Julia Schweiger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Schweiger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Schweiger more than expected).

Fields of papers citing papers by Julia Schweiger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia Schweiger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Schweiger. The network helps show where Julia Schweiger may publish in the future.

Co-authorship network of co-authors of Julia Schweiger

This figure shows the co-authorship network connecting the top 25 collaborators of Julia Schweiger. A scholar is included among the top collaborators of Julia Schweiger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia Schweiger. Julia Schweiger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chacko, Ravi V., Timothy O. Laumann, Christine Horan, et al.. (2025). Psilocybin’s acute and persistent brain effects: a precision imaging drug trial. Scientific Data. 12(1). 941–941. 1 indexed citations

Holzer, Katherine J., Emily Lenard, Bethany R Tellor Pennington, et al.. (2023). A Perioperative Mental Health Intervention for Depressed and Anxious Older Surgical Patients: Results From a Feasibility Study. American Journal of Geriatric Psychiatry. 32(2). 205–219. 10 indexed citations

Fritz, Bradley A., Bethany R Tellor Pennington, Catherine M. Dalton, et al.. (2023). Ketamine for postoperative avoidance of depressive symptoms: the K-PASS feasibility randomised trial. SHILAP Revista de lepidopterología. 9. 100245–100245. 4 indexed citations

Nicol, Ginger E., et al.. (2022). Use of an Interactive Obesity Treatment Approach in Individuals With Severe Mental Illness: Feasibility, Acceptability, and Proposed Engagement Criteria. JMIR Formative Research. 6(12). e38496–e38496. 4 indexed citations

Siegel, Joshua S., Ben Julian A. Palanca, Beau M. Ances, et al.. (2021). Prolonged ketamine infusion modulates limbic connectivity and induces sustained remission of treatment-resistant depression. Psychopharmacology. 238(4). 1157–1169. 36 indexed citations

Nicol, Ginger E., Christopher Metts, Michael Yingling, et al.. (2020). A Smartphone-Based Technique to Detect Dynamic User Preferences for Tailoring Behavioral Interventions: Observational Utility Study of Ecological Daily Needs Assessment. JMIR mhealth and uhealth. 8(11). e18609–e18609. 9 indexed citations

Lenze, Eric J., Caline Mattar, Charles F. Zorumski, et al.. (2020). Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19. JAMA. 324(22). 2292–2292. 333 indexed citations breakdown →

Nicol, Ginger E., Rachel P. Kolko, Eric J. Lenze, et al.. (2019). Adiposity, Hepatic Triglyceride, and Carotid Intima Media Thickness During Behavioral Weight Loss Treatment in Antipsychotic-Treated Youth: A Randomized Pilot Study. Journal of Child and Adolescent Psychopharmacology. 29(6). 439–447. 8 indexed citations

Kharasch, Evan D., Jane Blood, Angela Stevens, et al.. (2018). Bioequivalence and Therapeutic Equivalence of Generic and Brand Bupropion in Adults With Major Depression: A Randomized Clinical Trial. Clinical Pharmacology & Therapeutics. 105(5). 1164–1174. 14 indexed citations

10.

Bogdan, Ryan, et al.. (2017). Effects of Cable News Watching on Older Adults’ Physiological and Self-Reported Stress and Cognitive Function. The International Journal of Aging and Human Development. 87(2). 111–123. 6 indexed citations

11.

Nicol, Ginger E., Debra Haire‐Joshu, Alexis E. Duncan, et al.. (2016). Getting to More Effective Weight Management in Antipsychotic-Treated Youth: A Survey of Barriers and Preferences. Childhood Obesity. 12(1). 70–76. 10 indexed citations

12.

Nicol, Ginger E., Rachel P. Kolko, Thrudur Gunnarsdottir, et al.. (2016). Behavioral Weight Loss Treatment for Youth Treated With Antipsychotic Medications. SHILAP Revista de lepidopterología. 4(2). 96–104. 9 indexed citations

13.

Lenze, Eric J., Nuri B. Farber, Evan D. Kharasch, et al.. (2016). Ninety-six hour ketamine infusion with co-administered clonidine for treatment-resistant depression: A pilot randomised controlled trial. The World Journal of Biological Psychiatry. 17(3). 230–238. 35 indexed citations

14.

Nicol, Ginger E., Lisa de las Fuentes, Amy E. Riek, et al.. (2015). Adiposity and Cardiometabolic Risk in Children With and Without Antipsychotic Drug Treatment. The Journal of Clinical Endocrinology & Metabolism. 100(9). 3418–3426. 1 indexed citations

15.

Haupt, Dan, et al.. (2007). Adiposity and Insulin Sensitivity Derived from Intravenous Glucose Tolerance Tests in Antipsychotic-Treated Patients. Neuropsychopharmacology. 32(12). 2561–2569. 36 indexed citations

16.

Haupt, Dan, et al.. (2004). Plasma Leptin and Adiposity During Antipsychotic Treatment of Schizophrenia. Neuropsychopharmacology. 30(1). 184–191. 54 indexed citations

17.

Newcomer, John W., et al.. (2003). Fasting plasma lipids, glucose and insulin, and C-reactive protein are related to adiposity in schizophrenia. Schizophrenia Research. 60(1). 363–363. 1 indexed citations

18.

Melson, Angela K., Gregg Selke, Julia Schweiger, Nuri B. Farber, & John W. Newcomer. (2003). Relationship between plasma leptin and memory performance in humans with and without schizophrenia. Schizophrenia Research. 60(1). 147–148. 1 indexed citations

19.

Fucetola, Robert, Dan Haupt, Benjamin P. Cooper, et al.. (2002). Insulin resistance measured with euglycemic clamps during antipsychotic treatment of schizophrenia. 89514. 5 indexed citations

20.

Newcomer, John W., Dan Haupt, Robert Fucetola, et al.. (2002). Abnormalities in Glucose Regulation During Antipsychotic Treatment of Schizophrenia. Archives of General Psychiatry. 59(4). 337–337. 412 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact